Loading…
Royal Arc Electrodes (ROYALARC)₹152.00+1.33%Electrodes & Refractories
In the Mar 2026 quarter (standalone), Royal Arc Electrodes reported sales of ₹63.05 Cr, up 12.5% from Mar 2025, and net profit of ₹5.99 Cr, down 0.3% year on year. For the year to Mar 2026, sales were ₹116 Cr and net profit ₹9.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 46.01 | 56.06 | 53.06 | 63.05 |
| Expenses | 40.07 | 46.11 | 46.09 | 55.09 |
| Operating Profit | 5.01 | 10.02 | 7.02 | 9.02 |
| OPM % | 11.9% | 17.0% | 13.0% | 14.0% |
| Other Income | 0.00 | 0.00 | 1.01 | 1.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 2.01 | 2.01 | 2.01 |
| Profit before tax | 3.99 | 7.99 | 5.99 | 7.98 |
| Tax % | 26.9% | 24.0% | 25.0% | 27.0% |
| Exceptional items | 0.00 | −0.38 | 0.00 | 0.00 |
| Net Profit | 2.99 | 6.01 | 3.99 | 5.99 |
| EPS (Rs) | 3.39 | 5.30 | 3.89 | 5.17 |
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 64.98 | 63.98 | 64.06 | 43.02 | 63.03 | 97.01 | 99.97 | 102 | 116 |
| Expenses | 59.14 | 58.18 | 61.12 | 40.11 | 59.10 | 82.16 | 83.15 | 87.21 | 101 |
| Operating Profit | 6.01 | 6.01 | 3.01 | 3.01 | 4.01 | 15.03 | 17.02 | 15.03 | 15.04 |
| OPM % | 9.0% | 9.0% | 5.0% | 7.0% | 6.0% | 15.0% | 17.0% | 15.0% | 13.0% |
| Other Income | 0.00 | 0.00 | 1.01 | 1.99 | 2.01 | 1.01 | 1.01 | 0.00 | 2.01 |
| Interest | 3.01 | 3.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 | 4.01 |
| Profit before tax | 1.99 | 1.99 | 1.99 | 1.99 | 2.99 | 12.97 | 15.97 | 11.98 | 13.97 |
| Tax % | 37.0% | 34.0% | 23.0% | 26.9% | 25.0% | 26.9% | 26.0% | 25.0% | 26.0% |
| Exceptional items | 0.00 | 0.00 | 0.02 | −0.15 | 0.02 | −0.19 | 0.00 | −0.24 | 0.00 |
| Net Profit | 0.99 | 1.01 | 0.99 | 2.01 | 2.01 | 10.01 | 12.01 | 9.01 | 9.99 |
| EPS (Rs) | 5.34 | 6.49 | 6.55 | 8.64 | 11.66 | 52.62 | 13.05 | 8.13 | 9.06 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.0% |
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 8.98 | 10.99 | 10.98 |
| Reserves | 9.01 | 10.99 | 14.99 | 16.99 | 19.01 | 28.99 | 32.99 | 60.97 | 69.93 |
| Borrowings | 28.01 | 24.02 | 12.01 | 8.01 | 8.01 | 1.01 | 0.00 | 1.01 | 0.00 |
| Other Liabilities | 13.03 | 11.99 | 10.01 | 11.98 | 13.99 | 12.04 | 10.01 | 7.99 | 10.05 |
| Total Liabilities | 52.04 | 47.99 | 39.00 | 38.97 | 42.00 | 44.03 | 51.98 | 80.96 | 90.96 |
| Fixed Assets | 21.05 | 18.05 | 15.03 | 16.02 | 15.03 | 14.04 | 18.03 | 21.04 | 25.04 |
| CWIP | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 2.01 | 5.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 2.01 |
| Other Assets | 29.98 | 29.94 | 24.97 | 23.95 | 27.97 | 28.98 | 32.93 | 56.91 | 58.90 |
| Inventories | 13.49 | 12.97 | 10.94 | 8.77 | 10.88 | 6.09 | 9.07 | 14.32 | 13.22 |
| Trade receivables | 9.97 | 10.68 | 10.84 | 10.67 | 13.11 | 16.48 | 20.73 | 20.99 | 25.80 |
| Cash & equivalents | 1.37 | 1.37 | 0.72 | 0.29 | 0.04 | 3.01 | 0.95 | 19.29 | 14.46 |
| Total Assets | 52.04 | 47.99 | 39.00 | 38.97 | 42.00 | 44.03 | 51.98 | 80.96 | 90.96 |
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 7.01 | 3.01 | 6.01 | 7.01 | 2.01 | 13.01 | 6.01 | 4.01 | 8.01 |
| Cash from investing activity | −8.03 | 2.01 | 1.01 | −3.01 | −1.01 | −2.01 | −6.02 | −7.02 | −11.04 |
| Cash from financing activity | −1.01 | −5.01 | −8.03 | −5.01 | −2.01 | −7.02 | −2.01 | 21.04 | −1.01 |
| Net cash flow | −2.01 | 0.00 | −2.01 | 0.00 | 0.00 | 3.01 | −2.01 | 18.04 | −5.01 |
| Capex | 8.18 | 0.12 | 0.22 | 2.58 | 1.15 | 1.18 | 5.09 | 7.77 | 11.83 |
| Free cash flow | −1.01 | 2.01 | 6.02 | 5.02 | 1.01 | 11.04 | 1.01 | −4.01 | −4.01 |
| CFO / OP % | 132.0% | 51.0% | 176.0% | 252.0% | 77.0% | 88.0% | 56.0% | 49.0% | 73.0% |
| Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 56 | 61 | 61 | 90 | 76 | 62 | 75 | 75 | 81 |
| Inventory days | 103 | 103 | 82 | 101 | 83 | 32 | 49 | 74 | 56 |
| Days payable | 76 | 69 | 55 | 95 | 79 | 42 | 30 | 25 | 7 |
| Cash conversion cycle | 82 | 95 | 89 | 96 | 80 | 52 | 95 | 124 | 131 |
| Working capital days | 96 | 103 | 40 | 67 | 51 | 52 | 82 | 106 | 112 |
| ROCE % | — | 11.9% | — | 11.9% | 14.0% | 46.0% | 44.0% | 21.9% | 18.0% |
For the Mar 2026 quarter, Royal Arc Electrodes reported sales of ₹63.05 Cr, up 12.5% year on year and net profit of ₹5.99 Cr, down 0.3% year on year. The operating margin was 14.0%.
Royal Arc Electrodes' sales for the year to Mar 2026 were ₹116 Cr.
Net profit for the year to Mar 2026 was ₹9.99 Cr. Earnings per share over the same trailing period were ₹9.06.
Royal Arc Electrodes reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹14.46 Cr.
Cash from operations was ₹8.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹4.01 Cr.